recurrent rectal cancer
Showing 1 - 25 of 50
Recurrent Rectal Cancer Trial in Saint Louis (Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy, MEVION
Recruiting
- Recurrent Rectal Cancer
- Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy
- MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
-
Saint Louis, MissouriWashington University School of Medicine
Dec 8, 2022
Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Not yet recruiting
- Recurrent Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 17, 2022
Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,
Active, not recruiting
- Recurrent Rectal Cancer
- +6 more
- trametinib
- +2 more
-
Saint Louis, Missouri
- +3 more
Feb 15, 2022
Rectal Cancer, Colorectal Cancer, Colon Cancer Trial in London (Microstim 2v2 Stimulator)
Active, not recruiting
- Rectal Cancer
- +7 more
- Microstim 2v2 Stimulator
-
London, Greater London, United KingdomLondon North West University Healthcare NHS Trust
Oct 28, 2021
Comprehensive Gene Sequencing in Guiding Treatment
Completed
- Recurrent Breast Cancer
- +7 more
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021
PelvEx 4: Advanced Pelvic Malignancy and Role of
Not yet recruiting
- Multidisciplinary Communication
- +4 more
- No specific intervention; cases are retrospective and patients have already been treated.
-
Dublin, IrelandSt. Vincent's Hospital
Oct 12, 2021
Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond
Completed
- Mucinous Adenocarcinoma of the Rectum
- +9 more
- intensity-modulated radiation therapy
- +4 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Jul 19, 2021
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIA Colon Cancer Trial in Cleveland (positron emission tomography,
Completed
- Recurrent Colon Cancer
- +17 more
- positron emission tomography
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Apr 26, 2021
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent
Recruiting
- Recurrent Rectal Cancer
- +2 more
- CTV
-
Beijing, Beijing, ChinaPeking Unnversity Third Hospital
Jan 13, 2021
Recurrent Rectal Cancer Trial in Toronto (device, radiation, drug)
Unknown status
- Recurrent Rectal Cancer
- Magnetic resonance-guided focused ultrasound
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Dec 15, 2020
Rectal Cancer, Recurrent Rectal Cancer Trial in Netherlands (SGM-101)
Recruiting
- Rectal Cancer
- Recurrent Rectal Cancer
-
Amsterdam, Netherlands
- +3 more
Nov 23, 2020
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory
Terminated
- Adenocarcinoma of the Colon
- +5 more
- saracatinib
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jul 29, 2019
Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Columbus, Nashville
Unknown status
- Mucinous Adenocarcinoma of the Colon
- +7 more
- panitumumab
- +3 more
-
Columbus, Ohio
- +1 more
Mar 25, 2019
Liver Metastases, Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum Trial in Philadelphia
Terminated
- Liver Metastases
- +10 more
- irinotecan-eluting beads
- hepatic artery embolization
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 22, 2018
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in Duarte (MEK inhibitor MEK162, leucovorin
Completed
- Recurrent Colon Cancer
- +5 more
- MEK inhibitor MEK162
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 23, 2018
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer Trial in United States (sorafenib tosylate, bevacizumab)
Completed
- Recurrent Colon Cancer
- +3 more
- sorafenib tosylate
- bevacizumab
-
Scottsdale, Arizona
- +210 more
Aug 7, 2017
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Rochester, New York, Columbus (FOLFOX
Withdrawn
- Adenocarcinoma of the Colon
- +7 more
- FOLFOX regimen
- +5 more
-
Rochester, Minnesota
- +2 more
Apr 3, 2017
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Terminated
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +33 more
- Ipilimumab
- Radiation therapy
-
Stanford, CaliforniaStanford University
Jan 12, 2017
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV A Bladder Cancer Trial in Columbus (PET Scan, CT Scan, fludeoxyglucose
Completed
- Recurrent Colon Cancer
- +5 more
- PET Scan
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 3, 2016
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,
Completed
- Adenocarcinoma of the Colon
- +66 more
- cetuximab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2015
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer Trial in Los Angeles (drug, procedure, genetic, other)
Terminated
- Recurrent Colon Cancer
- +3 more
- panobinostat
- +9 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
May 26, 2015
Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B
Completed
- Recurrent Colon Cancer
- +13 more
- Detox-B adjuvant
- ras peptide cancer vaccine
-
Bethesda, MarylandMedicine Branch
Apr 27, 2015
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Toronto (erlotinib HCl,
Completed
- Adenocarcinoma of the Colon
- +5 more
- erlotinib hydrochloride
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Apr 14, 2015
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Boston (biological, drug, other)
Completed
- Adenocarcinoma of the Colon
- +7 more
- pertuzumab
- +8 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 11, 2015